Endolymphatic hydrops perspectives 2012
Endolymphatic hydrops remains a significant cause of morbidity secondary to vertigo, hearing loss, and tinnitus. The purpose of this report is to summarize the most clinically relevant publications on endolymphatic hydrops over the past 2 years. Hydrops has historically been a diagnosis of exclusion...
Gespeichert in:
| Veröffentlicht in: | Current opinion in otolaryngology & head and neck surgery 2012-10, Vol.20 (5), p.416-419 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 419 |
|---|---|
| container_issue | 5 |
| container_start_page | 416 |
| container_title | Current opinion in otolaryngology & head and neck surgery |
| container_volume | 20 |
| creator | Pierce, Nathan E Antonelli, Patrick J |
| description | Endolymphatic hydrops remains a significant cause of morbidity secondary to vertigo, hearing loss, and tinnitus. The purpose of this report is to summarize the most clinically relevant publications on endolymphatic hydrops over the past 2 years.
Hydrops has historically been a diagnosis of exclusion, but recent efforts has shown a role for MRI with intratympanic gadolinium. Cochrane reviews of intratympanic dexamethasone and gentamicin found inadequate level 1 evidence to support their use.
High-level evidence to guide therapy is lacking. MRI holds potential for definitive diagnosis. |
| doi_str_mv | 10.1097/MOO.0b013e328357a6c8 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1038612810</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1038612810</sourcerecordid><originalsourceid>FETCH-LOGICAL-c307t-81d64bcdde317c791e7e8b7ce1ed60f9630137d90ffd788b8549022b1fed18993</originalsourceid><addsrcrecordid>eNpdkEtPwzAQhC0EoqXwDxDqDS4pu3bixxFV5SEV9QLnKLE3alDSBDtFyr_HqIUDp9nDzOzoY-waYYFg1P3rZrOAElCQ4FpkqpBWn7ApZgITaYw-jTdInZgM9IRdhPABAKmU4pxNODfAU5RTdrvaua4Z235bDLWdb0fnuz7Me_KhJzvUXxTmHJBfsrOqaAJdHXXG3h9Xb8vnZL15elk-rBMrQA2JRifT0jpHApVVBkmRLpUlJCehMlLEwcoZqCqntC51lsYlvMSKHGpjxIzdHXp7333uKQx5WwdLTVPsqNuHHEFoiVxHnbH0YLW-C8FTlfe-bgs_RlP-gyiPiPL_iGLs5vhhX7bk_kK_TMQ3vF9haQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1038612810</pqid></control><display><type>article</type><title>Endolymphatic hydrops perspectives 2012</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>Pierce, Nathan E ; Antonelli, Patrick J</creator><creatorcontrib>Pierce, Nathan E ; Antonelli, Patrick J</creatorcontrib><description>Endolymphatic hydrops remains a significant cause of morbidity secondary to vertigo, hearing loss, and tinnitus. The purpose of this report is to summarize the most clinically relevant publications on endolymphatic hydrops over the past 2 years.
Hydrops has historically been a diagnosis of exclusion, but recent efforts has shown a role for MRI with intratympanic gadolinium. Cochrane reviews of intratympanic dexamethasone and gentamicin found inadequate level 1 evidence to support their use.
High-level evidence to guide therapy is lacking. MRI holds potential for definitive diagnosis.</description><identifier>ISSN: 1068-9508</identifier><identifier>EISSN: 1531-6998</identifier><identifier>DOI: 10.1097/MOO.0b013e328357a6c8</identifier><identifier>PMID: 22902416</identifier><language>eng</language><publisher>United States</publisher><subject>Adrenal Cortex Hormones - therapeutic use ; Anti-Bacterial Agents - therapeutic use ; Contrast Media ; Endolymphatic Hydrops - complications ; Endolymphatic Hydrops - diagnosis ; Female ; Follow-Up Studies ; Hearing Loss, Sensorineural - drug therapy ; Hearing Loss, Sensorineural - etiology ; Hearing Loss, Sensorineural - physiopathology ; Humans ; Image Enhancement - methods ; Magnetic Resonance Imaging - methods ; Male ; Meniere Disease - drug therapy ; Meniere Disease - etiology ; Meniere Disease - physiopathology ; Risk Assessment ; Tinnitus - drug therapy ; Tinnitus - etiology ; Tinnitus - physiopathology ; Treatment Outcome ; Vertigo - drug therapy ; Vertigo - etiology ; Vertigo - physiopathology</subject><ispartof>Current opinion in otolaryngology & head and neck surgery, 2012-10, Vol.20 (5), p.416-419</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c307t-81d64bcdde317c791e7e8b7ce1ed60f9630137d90ffd788b8549022b1fed18993</citedby><cites>FETCH-LOGICAL-c307t-81d64bcdde317c791e7e8b7ce1ed60f9630137d90ffd788b8549022b1fed18993</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22902416$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pierce, Nathan E</creatorcontrib><creatorcontrib>Antonelli, Patrick J</creatorcontrib><title>Endolymphatic hydrops perspectives 2012</title><title>Current opinion in otolaryngology & head and neck surgery</title><addtitle>Curr Opin Otolaryngol Head Neck Surg</addtitle><description>Endolymphatic hydrops remains a significant cause of morbidity secondary to vertigo, hearing loss, and tinnitus. The purpose of this report is to summarize the most clinically relevant publications on endolymphatic hydrops over the past 2 years.
Hydrops has historically been a diagnosis of exclusion, but recent efforts has shown a role for MRI with intratympanic gadolinium. Cochrane reviews of intratympanic dexamethasone and gentamicin found inadequate level 1 evidence to support their use.
High-level evidence to guide therapy is lacking. MRI holds potential for definitive diagnosis.</description><subject>Adrenal Cortex Hormones - therapeutic use</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Contrast Media</subject><subject>Endolymphatic Hydrops - complications</subject><subject>Endolymphatic Hydrops - diagnosis</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Hearing Loss, Sensorineural - drug therapy</subject><subject>Hearing Loss, Sensorineural - etiology</subject><subject>Hearing Loss, Sensorineural - physiopathology</subject><subject>Humans</subject><subject>Image Enhancement - methods</subject><subject>Magnetic Resonance Imaging - methods</subject><subject>Male</subject><subject>Meniere Disease - drug therapy</subject><subject>Meniere Disease - etiology</subject><subject>Meniere Disease - physiopathology</subject><subject>Risk Assessment</subject><subject>Tinnitus - drug therapy</subject><subject>Tinnitus - etiology</subject><subject>Tinnitus - physiopathology</subject><subject>Treatment Outcome</subject><subject>Vertigo - drug therapy</subject><subject>Vertigo - etiology</subject><subject>Vertigo - physiopathology</subject><issn>1068-9508</issn><issn>1531-6998</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkEtPwzAQhC0EoqXwDxDqDS4pu3bixxFV5SEV9QLnKLE3alDSBDtFyr_HqIUDp9nDzOzoY-waYYFg1P3rZrOAElCQ4FpkqpBWn7ApZgITaYw-jTdInZgM9IRdhPABAKmU4pxNODfAU5RTdrvaua4Z235bDLWdb0fnuz7Me_KhJzvUXxTmHJBfsrOqaAJdHXXG3h9Xb8vnZL15elk-rBMrQA2JRifT0jpHApVVBkmRLpUlJCehMlLEwcoZqCqntC51lsYlvMSKHGpjxIzdHXp7333uKQx5WwdLTVPsqNuHHEFoiVxHnbH0YLW-C8FTlfe-bgs_RlP-gyiPiPL_iGLs5vhhX7bk_kK_TMQ3vF9haQ</recordid><startdate>201210</startdate><enddate>201210</enddate><creator>Pierce, Nathan E</creator><creator>Antonelli, Patrick J</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201210</creationdate><title>Endolymphatic hydrops perspectives 2012</title><author>Pierce, Nathan E ; Antonelli, Patrick J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c307t-81d64bcdde317c791e7e8b7ce1ed60f9630137d90ffd788b8549022b1fed18993</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Adrenal Cortex Hormones - therapeutic use</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Contrast Media</topic><topic>Endolymphatic Hydrops - complications</topic><topic>Endolymphatic Hydrops - diagnosis</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Hearing Loss, Sensorineural - drug therapy</topic><topic>Hearing Loss, Sensorineural - etiology</topic><topic>Hearing Loss, Sensorineural - physiopathology</topic><topic>Humans</topic><topic>Image Enhancement - methods</topic><topic>Magnetic Resonance Imaging - methods</topic><topic>Male</topic><topic>Meniere Disease - drug therapy</topic><topic>Meniere Disease - etiology</topic><topic>Meniere Disease - physiopathology</topic><topic>Risk Assessment</topic><topic>Tinnitus - drug therapy</topic><topic>Tinnitus - etiology</topic><topic>Tinnitus - physiopathology</topic><topic>Treatment Outcome</topic><topic>Vertigo - drug therapy</topic><topic>Vertigo - etiology</topic><topic>Vertigo - physiopathology</topic><toplevel>online_resources</toplevel><creatorcontrib>Pierce, Nathan E</creatorcontrib><creatorcontrib>Antonelli, Patrick J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Current opinion in otolaryngology & head and neck surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pierce, Nathan E</au><au>Antonelli, Patrick J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Endolymphatic hydrops perspectives 2012</atitle><jtitle>Current opinion in otolaryngology & head and neck surgery</jtitle><addtitle>Curr Opin Otolaryngol Head Neck Surg</addtitle><date>2012-10</date><risdate>2012</risdate><volume>20</volume><issue>5</issue><spage>416</spage><epage>419</epage><pages>416-419</pages><issn>1068-9508</issn><eissn>1531-6998</eissn><abstract>Endolymphatic hydrops remains a significant cause of morbidity secondary to vertigo, hearing loss, and tinnitus. The purpose of this report is to summarize the most clinically relevant publications on endolymphatic hydrops over the past 2 years.
Hydrops has historically been a diagnosis of exclusion, but recent efforts has shown a role for MRI with intratympanic gadolinium. Cochrane reviews of intratympanic dexamethasone and gentamicin found inadequate level 1 evidence to support their use.
High-level evidence to guide therapy is lacking. MRI holds potential for definitive diagnosis.</abstract><cop>United States</cop><pmid>22902416</pmid><doi>10.1097/MOO.0b013e328357a6c8</doi><tpages>4</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1068-9508 |
| ispartof | Current opinion in otolaryngology & head and neck surgery, 2012-10, Vol.20 (5), p.416-419 |
| issn | 1068-9508 1531-6998 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1038612810 |
| source | MEDLINE; Journals@Ovid Complete |
| subjects | Adrenal Cortex Hormones - therapeutic use Anti-Bacterial Agents - therapeutic use Contrast Media Endolymphatic Hydrops - complications Endolymphatic Hydrops - diagnosis Female Follow-Up Studies Hearing Loss, Sensorineural - drug therapy Hearing Loss, Sensorineural - etiology Hearing Loss, Sensorineural - physiopathology Humans Image Enhancement - methods Magnetic Resonance Imaging - methods Male Meniere Disease - drug therapy Meniere Disease - etiology Meniere Disease - physiopathology Risk Assessment Tinnitus - drug therapy Tinnitus - etiology Tinnitus - physiopathology Treatment Outcome Vertigo - drug therapy Vertigo - etiology Vertigo - physiopathology |
| title | Endolymphatic hydrops perspectives 2012 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T12%3A10%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Endolymphatic%20hydrops%20perspectives%202012&rft.jtitle=Current%20opinion%20in%20otolaryngology%20&%20head%20and%20neck%20surgery&rft.au=Pierce,%20Nathan%20E&rft.date=2012-10&rft.volume=20&rft.issue=5&rft.spage=416&rft.epage=419&rft.pages=416-419&rft.issn=1068-9508&rft.eissn=1531-6998&rft_id=info:doi/10.1097/MOO.0b013e328357a6c8&rft_dat=%3Cproquest_cross%3E1038612810%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1038612810&rft_id=info:pmid/22902416&rfr_iscdi=true |